We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Heron Therapeutics
HRTX
$92M
| $1.37M | ﹤0.01% |
+494,354
| New | +$1.24M |
|
1502
Nektar Therapeutics
NKTR
$2.39B
| $1.37M | ﹤0.01% |
98,082
-61,001
| -38% | -$639K |
|
1503
Nelnet
NNI
$4.92B
| $1.36M | ﹤0.01% |
14,400
-2,771
| -16% | -$244K |
|
1504
Marcus Corp
MCS
$766M
| $1.36M | ﹤0.01% |
95,464
-77,932
| -45% | -$1.1M |
|
1505
ALX Oncology
ALXO
$268M
| $1.36M | ﹤0.01% |
121,546
+109,977
| +951% | +$1.54M |
|
1506
iShares MSCI Turkey ETF
TUR
$204M
| $1.35M | ﹤0.01% |
+37,564
| New | +$1.34M |
|
|
EGRX
1507
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.35M | ﹤0.01% |
257,469
+113,643
| +79% | +$624K |
|
1508
Pharvaris
PHVS
$2.35B
| $1.34M | ﹤0.01% |
58,169
-1,955
| -3% | -$51.9K |
|
|
GDEN
1509
DELISTED
Golden Entertainment
GDEN
| $1.33M | ﹤0.01% |
+36,124
| New | +$1.34M |
|
1510
Boston Omaha
BOC
$435M
| $1.32M | ﹤0.01% |
85,445
-44,718
| -34% | -$704K |
|
1511
Xometry
XMTR
$4.58B
| $1.32M | ﹤0.01% |
78,016
+50,036
| +179% | +$1.36M |
|
1512
CoStar Group
CSGP
$12.4B
| $1.31M | ﹤0.01% |
13,612
-144,507
| -91% | -$12.4M |
|
1513
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
| $1.31M | ﹤0.01% |
7,000
-8,644
| -55% | -$1.51M |
|
1514
Targa Resources
TRGP
$56.2B
| $1.31M | ﹤0.01% |
+11,708
| New | +$1.1M |
|
1515
Gerdau
GGB
$9.72B
| $1.31M | ﹤0.01% |
+355,487
| New | +$1.29M |
|
1516
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.31M | ﹤0.01% |
+40,000
| New | +$1.3M |
|
1517
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.58B
| $1.31M | ﹤0.01% |
+19,284
| New | +$1.26M |
|
1518
Weis Markets
WMK
$1.9B
| $1.31M | ﹤0.01% |
20,271
-55,681
| -73% | -$3.48M |
|
1519
Quaker Houghton
KWR
$2.67B
| $1.3M | ﹤0.01% |
6,348
+1,478
| +30% | +$293K |
|
|
SRDX
1520
DELISTED
Surmodics
SRDX
| $1.29M | ﹤0.01% |
43,981
-8,573
| -16% | -$273K |
|
1521
NB Bancorp
NBBK
$1.01B
| $1.29M | ﹤0.01% |
+94,377
| New | +$1.32M |
|
1522
PUT
Snowflake
SNOW
$93.7B
| $1.29M | ﹤0.01% |
+8,000
| New | +$1.55M |
|
|
HUYA
1523
Huya Inc
HUYA
$561M
| $1.28M | ﹤0.01% |
282,400
-12,319
| -4% | -$44.6K |
|
1524
Lloyds Banking Group
LYG
$87.2B
| $1.28M | ﹤0.01% |
+493,464
| New | +$1.13M |
|
1525
Weave Communications
WEAV
$548M
| $1.27M | ﹤0.01% |
+110,672
| New | +$1.33M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.